  |
| Other TroVax Clinical Trials / Introduction |
|
With recruitment completed for the Phase III TRIST study in renal cancer, Oxford BioMedica is also progressing TroVax for the treatment of different forms of colorectal cancer in partnership with sanofi-aventis and also QUASAR (the clinical trial network). Both of these Phase III studies are due to commence patient recruitment in 2008. Please follow links below for basic information on these planned trials. More information for patients and clinicians will be provided as the trials begin. QUASAR Phase III trial - for stage II/III colorectal cancer FLAMENCO Phase III trial - for stage IV metastatic colorectal cancer Phase II trial - for hormone-refractory prostate cancer (HRPC)
Website by College Hill - Life Sciences |
